Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
Abroad (travel likely)RecruitingPHASE4
Conditions
Obesity · Knee Osteoarthritis · Osteoarthritis, Knee
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
St Vincents Hospital Melbourne, Fitzroy, Victoria, Australia
Contact: Principal Investigator (Sina Babazadeh)Western Health, Melbourne, Victoria, Australia
Contact: Principal Investigator (Phong Tran)Austin Health-Repatriation Hospital, Melbourne, Victoria, Australia
Contact: Principal Investigator (Elif Ekinci)Eastern Health, Melbourne, Victoria, Australia
Contact: Study coordinator (Sallie Castleman) · sallie.castleman3@easternhealth.org.au · +61 03 9871 3159Contact: Principal Investigator (Raphael Hau)
Study leads
Michelle M Dowsey
Principal Investigator
University of Melbourne